MiR-30c-5p/ROCK2 axis regulates cell proliferation, apoptosis and EMT via the PI3K/AKT signaling pathway in HG-induced HK-2 cells.

MiR-30c-5p/ROCK2 axis regulates cell proliferation, apoptosis and EMT via the PI3K/AKT signaling pathway in HG-induced HK-2 cells.
复制标题

在高糖诱导的HK - 2细胞中,miR - 30c - 5p/ROCK2轴通过PI3K/AKT信号通路调控细胞增殖、凋亡及上皮 - 间充质转化。

DOI:
10.1515/biol-2020-0089
复制
发表时间:
2020
期刊:
影响因子:
2.2
通讯作者:
Cui X
Cui X
中科院分区:
生物学4区
文献类型:
--
作者:
Cui L;Yu M;Cui X

文献摘要

参考文献

被引文献

相似文献

糖尿病肾病(DN)是糖尿病最常见的并发症之一。越来越多的证据表明microRNA-30c-5p(miR-30c-5p)参与DN的发病机制,但其机制尚未明确。因此,本研究旨在体外研究miR-30c-5p在人类DN进展中的生物学作用。与对照组相比,DN组织和高糖诱导的HK-2细胞的miR-30c-5p水平显着降低,而ROCK2表达显着升高。此外,miR-30c-5p 模拟物明显促进细胞增殖并阻止细胞凋亡和上皮间质转化(EMT)。然而,ROCK2是miR-30c-5p的靶基因,体外上调ROCK2可逆转miR-30c-5p模拟物对细胞增殖、凋亡和EMT的影响。此外,DN的发病机制由miR-30c-5p/ROCK2轴通过PI3K/AKT通路调控。 MiR-30c-5p通过PI3K/AKT通路靶向ROCK2调节细胞增殖、凋亡和EMT,为临床治疗DN提供了新的潜在靶点。
Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus. Increasing evidence suggests that microRNA-30c-5p (miR-30c-5p) participates in the pathogenesis of DN, but the mechanism has not been clearly understood. Therefore, this study aimed to investigate the biological role of miR-30c-5p in human DN progression in vitro. Compared with the controls, DN tissues and high glucose-induced HK-2 cells had significantly reduced miR-30c-5p levels, while ROCK2 expression was prominently elevated. Additionally, the miR-30c-5p mimic distinctly facilitated cell proliferation and blocked cell apoptosis and epithelial–mesenchymal transition (EMT). However, ROCK2 was a target gene of miR-30c-5p, and the effects of miR-30c-5p mimic on cell proliferation, apoptosis and EMT were reversed by ROCK2 upregulation in vitro. Furthermore, the pathogenesis of DN was regulated by the miR-30c-5p/ROCK2 axis via the PI3K/AKT pathway. MiR-30c-5p regulating cell proliferation, apoptosis and EMT through targeting ROCK2 via the PI3K/AKT pathway provides the novel potential target for clinical treatment of DN.
DOI: 10.1016/j.cell.2017.04.001
发表时间: 2017-04-20
期刊: Cell
影响因子: 64.5
作者:
Manning BD;Toker A
通讯作者: Toker A
DOI: 10.1371/journal.pone.0086520
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Lin G;Brownsey RW;Macleod KM
通讯作者: Macleod KM
DOI: 10.1089/ars.2017.7278
发表时间: 2018-08-01
影响因子: 6.6
作者:
Bai, Xiaoyan;Geng, Jian;Liu, Xiaoting
通讯作者: Liu, Xiaoting
DOI: 10.1046/j.1523-1755.2003.00300.x
发表时间: 2003-12-01
影响因子: 19.6
作者:
Kanda, T;Wakino, S;Saruta, T
通讯作者: Saruta, T
DOI: 10.1038/nrd4140
发表时间: 2013-11
期刊: Nature reviews. Drug discovery
影响因子: --
作者:
Ling H;Fabbri M;Calin GA
通讯作者: Calin GA